aTyr Pharma (ATYR) Stock Insights

ATYR price $0.13 +0.00 +3.55%

Ticker
ATYR
Price
$0.13
Change
+0.00 +3.55%
Market cap ?
$12.59M
P/E ?
-0.25
Forward P/E ?
0.45
Dividend yield ?
0.00%
Beta ?
0.53
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
62
Value
59
Quality
28
Growth
100

Stocklytics score rationale: value 59, quality 28, growth 100.

Financials

2016201720182019202020212022202320242025
00042200010455000010386000353000235000190000

aTyr Pharma, Inc., a biopharmaceutical firm established in San Diego, California, in 2005, is dedicated to the discovery and advancement of therapeutic solutions. Operating within the United States, the company's research focuses on pioneering novel immunological pathways to address various medical conditions. Its primary investigational drug, efzofitimod, functions as a selective modulator of NRP2. This compound is…

Fair value

ATYR fair value $5.55. Price $0.13. Price is 98% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 28.30K. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 98.09M. Net debt 1.29M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare ATYR

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.11—2.50M
2026-08-07-0.11-0.12189.56M—
2026-05-15-0.11-0.16——
2026-03-05-0.14-0.18—40.00K
2025-11-06-0.26-0.20190.00K20.00K
2025-08-07-0.22-0.18——
2025-05-07-0.17-0.19——
2025-03-13-0.18-0.23—15.56K
2024-11-07-0.23-0.22—21.67K
2024-08-13-0.23-0.22—20.00K
2024-05-02-0.23-0.24235.00K36.67K
2024-03-14-0.25-0.24—3.42M
2023-09-30-0.20-0.23353.00K1.50M
2023-06-30-0.22-0.28—611.67K
2023-03-31-0.29-0.35—2.36M
2023-03-09-0.26-0.4810.39M357.14K
2022-11-10-0.46-0.46—400.00K
2022-08-15-0.44-0.38—2.50M
2019-12-31-1.54—144.00K—
2019-09-30-1.47—184.00K—
2019-06-30-1.80—94.00K—
2019-03-31-2.54———
2018-12-31-2.92———
2018-09-30-3.33———
2018-06-30-4.88———
2018-03-31-5.01———
2017-12-31-5.40———
2017-09-30-6.07———
2017-06-30-7.14———
2017-03-31-7.91———
2016-12-31-7.42———
2016-09-30-8.16———
2016-06-30-9.10———
2016-03-31-9.53———
2015-12-31-9.78———
2015-09-30-6.73———
2015-06-30-10.41———
2015-03-31-5.63———
2014-12-31-102.16———
2014-09-30-9.22———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-01Yaras BrandonBuy410.00K$0.30123.00K
2026-10-01Yaras BrandonOther70.00K$3.48243.60K
2026-10-01Yaras BrandonOther28.45K$2.1962.45K
2026-10-01Yaras BrandonOther55.00K$1.5082.50K
2026-10-01Yaras BrandonOther84.14K$3.74314.69K
2026-10-01Yaras BrandonOther88.00K——
2026-05-27SCHIMMEL PAULBuy100.00K$0.5049.63K
2026-05-11Coughlin TimothyBuy50.00K$0.9547.50K
2026-05-11BENEVICH ERICBuy50.00K$0.9547.50K
2026-05-11Gross Jane ABuy50.00K$0.9547.50K
2026-05-11Lucas SvetlanaBuy50.00K$0.9547.50K
2026-05-11Zaknoen SaraBuy50.00K$0.9547.50K
2026-05-11SCHIMMEL PAULBuy50.00K$0.9547.50K
2026-02-04Shukla SanjaySell3.75K$0.983.66K
2026-02-04Broadfoot Jill MarieSell1.56K$0.981.52K
2026-02-04DENYES NANCYSell1.12K$0.981.09K
2026-02-03Shukla SanjayBuy10.38K——
2026-02-03Shukla SanjaySell10.38K——
2026-02-03Broadfoot Jill MarieBuy3.75K——
2026-02-03Broadfoot Jill MarieSell3.75K——
2026-02-03DENYES NANCYBuy2.69K——
2026-02-03DENYES NANCYSell2.69K——
2026-01-09Shukla SanjayBuy1.50M$0.711.07M
2026-01-09Broadfoot Jill MarieBuy412.50K$0.71293.99K
2026-01-09DENYES NANCYBuy412.50K$0.71293.99K
2025-10-09SCHIMMEL PAULBuy318.00K$0.94299.36K
2025-10-08SCHIMMEL PAULBuy682.00K$0.90612.44K
2025-05-01Zaknoen SaraBuy50.00K$3.34167.00K
2025-05-01SCHIMMEL PAULBuy50.00K$3.34167.00K
2025-05-01Lucas SvetlanaBuy50.00K$3.34167.00K
2025-05-01Gross Jane ABuy50.00K$3.34167.00K
2025-05-01BENEVICH ERICBuy50.00K$3.34167.00K
2025-05-01COUGHLIN TIMOTHYBuy50.00K$3.34167.00K
2025-03-17Gross Jane ABuy3.75K$4.0015.00K
2025-02-04Broadfoot Jill MarieSell1.25K$3.784.74K
2025-02-04DENYES NANCYSell899$3.783.40K
2025-02-03Shukla SanjayBuy10.38K——
2025-02-03Shukla SanjaySell10.38K——
2025-02-03Broadfoot Jill MarieBuy3.75K——
2025-02-03Broadfoot Jill MarieSell3.75K——
2025-02-03DENYES NANCYBuy2.69K——
2025-02-03DENYES NANCYSell2.69K——
2025-01-08Shukla SanjayBuy1.00M$3.743.74M
2025-01-08Broadfoot Jill MarieBuy275.00K$3.741.03M
2025-01-08DENYES NANCYBuy275.00K$3.741.03M
2024-12-10BENEVICH ERICBuy100.00K$3.29329.00K
2024-12-10BENEVICH ERICOther0——
2024-07-24SCHIMMEL PAULBuy52.30K$1.93101.04K
2024-07-23SCHIMMEL PAULBuy6.65K$1.8212.07K
2024-07-22SCHIMMEL PAULBuy41.05K$1.7471.50K
2024-06-05DENYES NANCYBuy5.00K$1.869.28K
2024-05-31Broadfoot Jill MarieBuy5.00K$1.798.95K
2024-05-31Shukla SanjayBuy20.00K$1.8136.14K
2024-05-30COUGHLIN TIMOTHYBuy50.00K$1.7587.50K
2024-05-22CLARKE JOHN KBuy24.00K$1.8644.64K
2024-05-22Gross Jane ABuy24.00K$1.8644.64K
2024-05-22Lucas SvetlanaBuy24.00K$1.8644.64K
2024-05-22SCHIMMEL PAULBuy24.00K$1.8644.64K
2024-05-22Zaknoen SaraBuy24.00K$1.8644.64K
2024-05-22COUGHLIN TIMOTHYBuy24.00K$1.8644.64K
2024-02-06Broadfoot Jill MarieSell1.59K$1.692.69K
2024-02-05Shukla SanjayBuy10.38K——
2024-02-05Shukla SanjaySell10.38K——
2024-02-05Broadfoot Jill MarieBuy3.75K——
2024-02-05Broadfoot Jill MarieSell3.75K——
2024-02-05DENYES NANCYBuy2.69K——
2024-02-05DENYES NANCYSell2.69K——
2024-01-05Shukla SanjayBuy600.00K$1.50900.00K
2024-01-05Broadfoot Jill MarieBuy150.00K$1.50225.00K
2024-01-05DENYES NANCYBuy150.00K$1.50225.00K
2023-12-12Shukla SanjayBuy12.00K$1.1814.14K
2023-12-11Shukla SanjayBuy3.00K$1.173.51K
2023-11-13Shukla SanjayBuy13.58K$1.1115.09K
2023-11-10Shukla SanjayBuy1.42K$1.141.62K
2023-07-28Shukla SanjayBuy15.00K$2.0130.22K
2023-05-17Zaknoen SaraBuy12.00K$2.5230.24K
2023-05-17SCHIMMEL PAULBuy12.00K$2.5230.24K
2023-05-17Lucas SvetlanaBuy12.00K$2.5230.24K
2023-05-17Gross Jane ABuy12.00K$2.5230.24K
2023-05-17COUGHLIN TIMOTHYBuy12.00K$2.5230.24K
2023-05-17COUGHLIN TIMOTHYBuy6.00K——
2023-05-17COUGHLIN TIMOTHYSell6.00K——
2023-05-17CLARKE JOHN KBuy12.00K$2.5230.24K
2023-05-10SCHIMMEL PAULBuy200.00K$2.25450.00K
2023-04-26Zaknoen SaraBuy6.00K——
2023-04-26Zaknoen SaraSell6.00K——
2023-04-26CLARKE JOHN KBuy6.00K——
2023-04-26CLARKE JOHN KSell6.00K——
2023-04-26SCHIMMEL PAULBuy6.00K——
2023-04-26SCHIMMEL PAULSell6.00K——
2023-04-26Lucas SvetlanaBuy6.00K——
2023-04-26Lucas SvetlanaSell6.00K——
2023-04-26Gross Jane ABuy6.00K——
2023-04-26Gross Jane ASell6.00K——
2023-04-26COUGHLIN TIMOTHYBuy6.00K——
2023-04-26COUGHLIN TIMOTHYSell6.00K——
2023-02-16Shukla SanjayBuy336.10K$2.19737.73K
2023-02-16Broadfoot Jill MarieBuy84.02K$2.19184.43K
2023-02-16DENYES NANCYBuy84.02K$2.19184.43K
2023-02-06Broadfoot Jill MarieSell1.57K$2.363.70K

Institutional holders

HolderSharesChangeChange %Value
No data yet.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

aTyr Pharma (ATYR) Stock Insights

ATYR$0.13+0.00 +3.55%

$12.59M

Market Cap

-0.25

P/E

0.45

Forward P/E

62

Score

Price History